Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Vascular Neurology
•
neuroc
When do you offer propranolol for treatment of familial cerebral cavernous malformations?
Related Questions
When should you seek hyperbaric oxygen therapy for patients with CRAO?
When would you consider intra-arterial thrombolysis for acute ischemic stroke?
How safe and effective is carotid stenting in carotid dissection?
Would you consider IV thrombolytics in patients with acute ischemic stroke, with or without a large vessel occlusion, if they have a history of von Willebrand disease (VWD), regardless of its type?
How does the presence of signs of cerebral edema influence your decision for thrombolysis and endovascular thrombectomy?
What is your approach to management and surveillance in low grade traumatic blunt ICA injury?
At what point should aspirin therapy for stable cardiovascular disease be discontinued in patients with a diagnosis of chronic cerebral microbleeds or possible Cerebral Amyloid Angiopathy?
How do you approach the decision of when to perform left heart catheterization in a patient with an NSTEMI who recently had an acute ischemic stroke?
When do you consider testing with stroke gene panels in young stroke patients?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
